sciencedirect.com/science/a...
Piperlongumine synergistically enhanc... - Advanced Prostate...
Piperlongumine synergistically enhances the antitumour activity sorafenib mediating ROS-AMPK activation targeting CPSF7 in liver cancer
Written by
Bigm789
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
Bigm789, you have posted a few times on the remarkably diverse anticancer effects along differing signalling pathways of Piperlongumine in various preclinical trials. If you have made any personal decision on dosage and brand of PL, please let us know.
Not what you're looking for?
You may also like...
Piperlongumine inhibits cell growth and enhances TRAIL-induced apoptosis in prostate cancer cells
https://www.apjtb.org/article.asp?issn=2221-1691;year=2020;volume=10;issue=5;spage=216;epage=223;aul
Breaking androgen receptor addiction of prostate cancer by targeting different functional domains in the treatment of advanced disease
Im not Castrate resistant but will eventually be so this is an important article in understanding...
